Andrew M. Kaunitz M.D., FACOG Professor & Associate Chair, Department of Obstetrics and Gynecology; Medical Director, UF Health Women's Specialists - Emerson Department: Department of Obstetrics and Gynecology Business Phone: (904) 244-3127 Business Email: andrew.kaunitz@jax.ufl.edu Appointments and Locations Board Certifications Obstetrics and Gynecology Show More Clinical Profile Specialties Obstetrics and Gynecology Interests Clinical Special Interests: Contraception and menopausal medicine; general gynecologyResearch Special Interests: Contraception; menopausal medicine Show More Publications 2021A Low 50-gram, 1-hour Glucose Challenge Test Value Predicts Neonatal Birth Weight Less than the 10th Percentile: A Systematic Review and Meta-Analysis.American journal of perinatology.38(8):841-847[DOI] 10.1055/s-0039-3402749.[PMID] 31986539.PubMed·Publisher's Site2021Cardiovascular disease (CVD) risk scores, age, or years since menopause to predict cardiovascular disease in the Women's Health Initiative.Menopause (New York, N.Y.).28(6):610-618[DOI] 10.1097/GME.0000000000001753.[PMID] 33950030.5 citations·PubMed·Publisher's Site2021Efficacy, safety, and tolerability of a levonorgestrel/ethinyl estradiol transdermal delivery system: Phase 3 clinical trial results.Contraception.103(3):137-143[DOI] 10.1016/j.contraception.2020.11.011.[PMID] 33259782.8 citations·PubMed·Publisher's Site2021Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results.Contraception.104(3):222-228[DOI] 10.1016/j.contraception.2021.05.002.[PMID] 34000251.15 citations·PubMed·Publisher's Site2021Genital powder use and risk of uterine cancer: A pooled analysis of prospective studies.International journal of cancer.148(11):2692-2701[DOI] 10.1002/ijc.33470.[PMID] 33433939.1 citations·PubMed·Publisher's Site2021Hormonal Contraception: Systemic Estrogen and Progestin Preparations.Clinical obstetrics and gynecology.64(4):721-738[DOI] 10.1097/GRF.0000000000000634.[PMID] 34668886.1 citations·PubMed·Publisher's Site2021Maintaining cognitive function in surgically menopausal women: the importance of estrogen.Menopause (New York, N.Y.).28(4):349-351[DOI] 10.1097/GME.0000000000001743.[PMID] 33570874.PubMed·Publisher's Site2021Pregnancy outcomes associated with an abnormal 50-g glucose screen during pregnancy: a systematic review and Meta-analysis.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.34(24):4132-4140[DOI] 10.1080/14767058.2019.1706473.[PMID] 31893960.2 citations·PubMed·Publisher's Site2021Risks of Testosterone for Postmenopausal Women.Endocrinology and metabolism clinics of North America.50(1):139-150[DOI] 10.1016/j.ecl.2020.10.007.[PMID] 33518182.PubMed·Publisher's Site2021Segesterone acetate serum levels with a regression model of continuous use of the segesterone acetate/ethinyl estradiol contraceptive vaginal system.Contraception.104(3):229-234[DOI] 10.1016/j.contraception.2021.03.024.[PMID] 33785318.PubMed·Publisher's Site2021Treatment of Women After Bilateral Salpingo-oophorectomy Performed Prior to Natural Menopause.JAMA.326(14):1429-1430[DOI] 10.1001/jama.2021.3305.[PMID] 34636868.4 citations·PubMed·Publisher's Site202017β-estradiol/progesterone in a single, oral, softgel capsule (TX-001HR) significantly increased the number of vasomotor symptom-free days in the REPLENISH trial.Menopause (New York, N.Y.).27(12):1382-1387[DOI] 10.1097/GME.0000000000001615.[PMID] 32740481.1 citations·PubMed·Publisher's Site2020Association of Powder Use in the Genital Area With Risk of Ovarian Cancer.JAMA.323(1):49-59[DOI] 10.1001/jama.2019.20079.[PMID] 31910280.29 citations·PubMed·Publisher's Site2020Best Practices for Counseling Adolescents about the Etonogestrel Implant.Journal of pediatric and adolescent gynecology.33(5):448-454[DOI] 10.1016/j.jpag.2020.06.022.[PMID] 32621879.16 citations·PubMed·Publisher's Site2020Does umbilical cord milking increase the risk of severe intraventricular hemorrhage in extreme preterm neonates? A multitreatment comparison.American journal of obstetrics and gynecology.223(4):590-592[DOI] 10.1016/j.ajog.2020.06.043.[PMID] 32593537.1 citations·PubMed·Publisher's Site2020Hormone therapy and sarcopenia: implications for the prevention of frailty as women age.Menopause (New York, N.Y.).27(5):496-497[DOI] 10.1097/GME.0000000000001541.[PMID] 32187132.PubMed·Publisher's Site2020In Reply.Menopause (New York, N.Y.).27(9):1097-1098[DOI] 10.1097/GME.0000000000001625.[PMID] 32852466.PubMed·Publisher's Site2020Intercepting Endometrial Cancer: Opportunities to Expand Access Using New Technology.Cancer prevention research (Philadelphia, Pa.).13(7):563-568[DOI] 10.1158/1940-6207.CAPR-19-0556.[PMID] 32047026.6 citations·PubMed·Publisher's Site2020Serial Bone Density Measurement and Incident Fracture Risk Discrimination in Postmenopausal Women.JAMA internal medicine.180(9):1232-1240[DOI] 10.1001/jamainternmed.2020.2986.[PMID] 32730575.24 citations·PubMed·Publisher's Site2020Surgical menopause: health implications and hormonal management.Menopause (New York, N.Y.).28(1):1-3[DOI] 10.1097/GME.0000000000001680.[PMID] 33048864.7 citations·PubMed·Publisher's Site2020The National Academies of Science, Engineering, and Medicine (NASEM) Report on Compounded Bioidentical Hormone Therapy.Menopause (New York, N.Y.).27(11):1199-1201[DOI] 10.1097/GME.0000000000001672.[PMID] 33110032.2 citations·PubMed·Publisher's Site2020The Women's Health Initiative trials of menopausal hormone therapy: lessons learned.Menopause (New York, N.Y.).27(8):918-928[DOI] 10.1097/GME.0000000000001553.[PMID] 32345788.13 citations·PubMed·Publisher's Site2020TX-001HR is associated with a clinically meaningful effect on severity of moderate to severe vasomotor symptoms in the REPLENISH trial.Menopause (New York, N.Y.).27(11):1236-1241[DOI] 10.1097/GME.0000000000001602.[PMID] 33110039.1 citations·PubMed·Publisher's Site2019Abnormal Uterine Bleeding in Reproductive-Age Women.JAMA.321(21):2126-2127[DOI] 10.1001/jama.2019.5248.[PMID] 31070673.7 citations·PubMed·Publisher's Site2019Associations of a Healthy Lifestyle Index With the Risks of Endometrial and Ovarian Cancer Among Women in the Women's Health Initiative Study.American journal of epidemiology.188(2):261-273[DOI] 10.1093/aje/kwy249.[PMID] 30407487.13 citations·PubMed·Publisher's Site2019Breast Cancer and the Obstetrician-Gynecologist: A Focus on Screening, Risk Assessment and Treatment of Survivors With Genitourinary Syndrome of Menopause.Clinical obstetrics and gynecology.62(4):634-643[DOI] 10.1097/GRF.0000000000000479.[PMID] 31259841.1 citations·PubMed·Publisher's Site2019Can initial vaginal bleeding patterns in etonogestrel implant users predict subsequent bleeding in the first 2 years of use?Contraception.100(4):264-268[DOI] 10.1016/j.contraception.2019.05.017.[PMID] 31176688.10 citations·PubMed·Publisher's Site2019Early onset of action with a 17β-estradiol, softgel, vaginal insert for treating vulvar and vaginal atrophy and moderate to severe dyspareunia.Menopause (New York, N.Y.).26(11):1259-1264[DOI] 10.1097/GME.0000000000001394.[PMID] 31688572.3 citations·PubMed·Publisher's Site2019Effects of ospemifene on genitourinary health assessed by prospective vulvar-vestibular photography and vaginal/vulvar health indices.Menopause (New York, N.Y.).26(9):994-1001[DOI] 10.1097/GME.0000000000001350.[PMID] 31453961.4 citations·PubMed·Publisher's Site2019Global Consensus Position Statement on the Use of Testosterone Therapy for Women.The journal of sexual medicine.16(9):1331-1337[DOI] 10.1016/j.jsxm.2019.07.012.[PMID] 31488288.13 citations·PubMed·Publisher's Site2019Global Consensus Position Statement on the use of Testosterone Therapy for Women.Maturitas.128():89-93[DOI] 10.1016/j.maturitas.2019.07.001.[PMID] 31484631.9 citations·PubMed·Publisher's Site2019Global Consensus Position Statement on the Use of Testosterone Therapy for Women.Climacteric : the journal of the International Menopause Society.22(5):429-434[DOI] 10.1080/13697137.2019.1637079.[PMID] 31474158.28 citations·PubMed·Publisher's Site2019Global Consensus Position Statement on the Use of Testosterone Therapy for Women.The Journal of clinical endocrinology and metabolism.104(10):4660-4666[DOI] 10.1210/jc.2019-01603.[PMID] 31498871.80 citations·PubMed·Publisher's Site2019Management of Menopause and the Role For Hormone Therapy.Clinical obstetrics and gynecology.62(4):677-686[DOI] 10.1097/GRF.0000000000000487.[PMID] 31503029.3 citations·PubMed·Publisher's Site2019Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy: A Randomized Trial.Annals of internal medicine.171(6):406-414[DOI] 10.7326/M19-0274.[PMID] 31499528.28 citations·PubMed·Publisher's Site2019Menopause Management Knowledge in Postgraduate Family Medicine, Internal Medicine, and Obstetrics and Gynecology Residents: A Cross-Sectional Survey.Mayo Clinic proceedings.94(2):242-253[DOI] 10.1016/j.mayocp.2018.08.033.[PMID] 30711122.18 citations·PubMed·Publisher's Site2019Metabolic and cardiovascular effects of TX-001HR in menopausal women with vasomotor symptoms.Climacteric : the journal of the International Menopause Society.22(6):610-616[DOI] 10.1080/13697137.2019.1640197.[PMID] 31364889.11 citations·PubMed·Publisher's Site2019Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms.Menopause (New York, N.Y.).26(5):506-512[DOI] 10.1097/GME.0000000000001271.[PMID] 30489424.13 citations·PubMed·Publisher's Site2019Povidone-iodine 1% is the most effective vaginal antiseptic for preventing post-cesarean endometritis: a systematic review and network meta-analysis.American journal of obstetrics and gynecology.221(3):261.e1-261.e20[DOI] 10.1016/j.ajog.2019.04.002.[PMID] 30954518.17 citations·PubMed·Publisher's Site2019Reproductive health care across the lifecourse of the female cancer patient.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.27(1):23-32[DOI] 10.1007/s00520-018-4360-5.[PMID] 30051202.6 citations·PubMed·Publisher's Site2019Vaginal estrogen: Underprescribed treatment for an underdiagnosed condition of menopausal women.Maturitas.121():83-85[DOI] 10.1016/j.maturitas.2018.08.001.[PMID] 30098845.PubMed·Publisher's Site2019Women harmed by vaginal laser for treatment of GSM-the latest casualties of fear and confusion surrounding hormone therapy.Menopause (New York, N.Y.).26(4):338-340[DOI] 10.1097/GME.0000000000001313.[PMID] 30789455.5 citations·PubMed·Publisher's Site2018A 17β-Estradiol-Progesterone Oral Capsule for Vasomotor Symptoms in Postmenopausal Women: A Randomized Controlled Trial.Obstetrics and gynecology.132(1):161-170[DOI] 10.1097/AOG.0000000000002645.[PMID] 29889748.36 citations·PubMed·Publisher's Site2018Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study.Menopause (New York, N.Y.).25(1):11-20[DOI] 10.1097/GME.0000000000000956.[PMID] 28816933.111 citations·PubMed·Publisher's Site2018Concern about US Preventive Services Task Force recommendation on hormone therapy for the primary prevention of chronic conditions in postmenopausal women.Menopause (New York, N.Y.).25(5):476-[DOI] 10.1097/GME.0000000000001100.[PMID] 29658911.3 citations·PubMed·Publisher's Site2018Contraception for midlife women: a review.Menopause (New York, N.Y.).25(7):817-827[DOI] 10.1097/GME.0000000000001073.[PMID] 29462093.8 citations·PubMed·Publisher's Site2018Extended Use of Systemic Menopausal Hormone Therapy.Clinical obstetrics and gynecology.61(3):517-522[DOI] 10.1097/GRF.0000000000000382.[PMID] 29781874.2 citations·PubMed·Publisher's Site2018Foreword: Managing Menopause by Combining Evidence With Clinical Judgment.Clinical obstetrics and gynecology.61(3):417-418[DOI] 10.1097/GRF.0000000000000387.[PMID] 29889666.PubMed·Publisher's Site2018Hormonal contraception and risk of breast cancer: a closer look.Menopause (New York, N.Y.).25(5):477-479[DOI] 10.1097/GME.0000000000001101.[PMID] 29557848.PubMed·Publisher's Site2018Improvement in sleep outcomes with a 17β-estradiol-progesterone oral capsule (TX-001HR) for postmenopausal women.Menopause (New York, N.Y.).26(6):622-628[DOI] 10.1097/GME.0000000000001278.[PMID] 30586005.16 citations·PubMed·Publisher's Site2018Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health.Menopause (New York, N.Y.).25(6):596-608[DOI] 10.1097/GME.0000000000001121.[PMID] 29762200.87 citations·PubMed·Publisher's Site2018Not time to abandon use of local vaginal hormone therapies.Menopause (New York, N.Y.).25(8):855-858[DOI] 10.1097/GME.0000000000001142.[PMID] 29894370.7 citations·PubMed·Publisher's Site2018Screening mammography for average-risk women.Menopause (New York, N.Y.).25(3):343-345[DOI] 10.1097/GME.0000000000001026.[PMID] 29257034.PubMed·Publisher's Site2018Vasomotor symptoms and the risk of incident venous thrombosis in postmenopausal women.Journal of thrombosis and haemostasis : JTH.16(5):886-892[DOI] 10.1111/jth.13993.[PMID] 29504242.1 citations·PubMed·Publisher's Site2017A systematic review and meta-analysis of hypocalciuria in pre-eclampsia.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.138(1):3-11[DOI] 10.1002/ijgo.12165.[PMID] 28369876.5 citations·PubMed·Publisher's Site2017Comparison of clinical outcomes among users of oral and transdermal estrogen therapy in the Women's Health Initiative Observational Study.Menopause (New York, N.Y.).24(10):1145-1153[DOI] 10.1097/GME.0000000000000899.[PMID] 28697036.14 citations·PubMed·Publisher's Site2017Contraceptive Considerations for Women with Gastrointestinal Disorders.Digestive diseases and sciences.62(1):54-63[DOI] 10.1007/s10620-016-4383-z.[PMID] 27885460.3 citations·PubMed·Publisher's Site2017Long-acting reversible contraception: an important solution to reduce unintended pregnancy.American journal of obstetrics and gynecology.216(5):539-[DOI] 10.1016/j.ajog.2017.03.004.[PMID] 28284931.PubMed·Publisher's Site2017Menopausal hormone therapy and national time trends in mortality: cautions regarding causal inference.Menopause (New York, N.Y.).24(8):874-876[DOI] 10.1097/GME.0000000000000886.[PMID] 28486245.2 citations·PubMed·Publisher's Site2017The 2017 Hormone Therapy Position Statement of the North American Menopause SocietyMenopause-the Journal of the North American Menopause Society.24(7):728-753[DOI] 10.1097/GME.0000000000000921.[PMID] .PubMed·Publisher's Site2017The cross-sectional association between vasomotor symptoms and hemostatic parameter levels in postmenopausal women.Menopause (New York, N.Y.).24(4):360-370[DOI] 10.1097/GME.0000000000000777.[PMID] 27922933.3 citations·PubMed·Publisher's Site2017The US etonogestrel implant mandatory clinical training and active monitoring programs: 6-year experience.Contraception.95(2):205-210[DOI] 10.1016/j.contraception.2016.07.012.[PMID] 27452317.20 citations·PubMed·Publisher's Site2017Vaginal estrogen in the treatment of genitourinary syndrome of menopause and risk of endometrial cancer: an assessment of recent studies provides reassurance.Menopause (New York, N.Y.).24(12):1329-1332[DOI] 10.1097/GME.0000000000000996.[PMID] 29040220.10 citations·PubMed·Publisher's Site2016An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas.Journal of minimally invasive gynecology.23(3):303-8[DOI] 10.1016/j.jmig.2015.12.012.[PMID] 26773577.13 citations·PubMed·Publisher's Site2016Clinical trials of new treatments for menopausal conditions: paying attention to race.Menopause (New York, N.Y.).23(6):589-90[DOI] 10.1097/GME.0000000000000637.[PMID] 27070806.PubMed·Publisher's Site2016Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians.The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.21(2):106-15[DOI] 10.3109/13625187.2015.1107894.[PMID] 26572318.22 citations·PubMed·Publisher's Site2016In Reply.Obstetrics and gynecology.127(5):966-967[DOI] 10.1097/AOG.0000000000001416.[PMID] 27101114.PubMed·Publisher's Site2016Menopause Management--Getting Clinical Care Back on Track.The New England journal of medicine.374(9):803-6[DOI] 10.1056/NEJMp1514242.[PMID] 26962899.108 citations·PubMed·Publisher's Site2016Single abnormal value on 3-hour oral glucose tolerance test during pregnancy is associated with adverse maternal and neonatal outcomes: a systematic review and metaanalysis.American journal of obstetrics and gynecology.215(3):287-97[DOI] 10.1016/j.ajog.2016.04.040.[PMID] 27133007.37 citations·PubMed·Publisher's Site2016Stopping systemic menopausal hormone therapy: Why, when and how.Maturitas.89():3-4[DOI] 10.1016/j.maturitas.2016.03.020.[PMID] 27180152.1 citations·PubMed·Publisher's Site2016U.S. Food and Drug Administration's Guidance Regarding Morcellation of Leiomyomas: Well-Intentioned, But Is It Harmful for Women?Obstetrics and gynecology.127(1):18-22[DOI] 10.1097/AOG.0000000000001157.[PMID] 26646134.39 citations·PubMed·Publisher's Site2016Use of systemic hormone therapy in BRCA mutation carriers.Menopause (New York, N.Y.).23(9):1026-7[DOI] 10.1097/GME.0000000000000724.[PMID] 27504919.19 citations·PubMed·Publisher's Site2015Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society.Menopause (New York, N.Y.).22(3):247-53[DOI] 10.1097/GME.0000000000000373.[PMID] 25314150.46 citations·PubMed·Publisher's Site2015Antenatal exposure to indomethacin increases the risk of severe intraventricular hemorrhage, necrotizing enterocolitis, and periventricular leukomalacia: a systematic review with metaanalysis.American journal of obstetrics and gynecology.212(4):505.e1-13[DOI] 10.1016/j.ajog.2014.10.1091.[PMID] 25448524.50 citations·PubMed·Publisher's Site2015Balancing the efficacy and safety of misoprostol: a meta-analysis comparing 25 versus 50 micrograms of intravaginal misoprostol for the induction of labour.BJOG : an international journal of obstetrics and gynaecology.122(4):468-76[DOI] 10.1111/1471-0528.12935.[PMID] 24989790.18 citations·PubMed·Publisher's Site2015Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials.JAMA oncology.1(3):296-305[DOI] 10.1001/jamaoncol.2015.0494.[PMID] 26181174.134 citations·PubMed·Publisher's Site2015Compounded bioidentical hormone therapy: time for a reality check?Menopause (New York, N.Y.).22(9):919-20[DOI] 10.1097/GME.0000000000000484.[PMID] 26035149.1 citations·PubMed·Publisher's Site2015Does Cervical Ripening With Foley Catheters Increase Infectious Morbidity? a Systematic Review With Meta-AnalysisObstetrics and Gynecology.125(1):64S-[DOI] .[PMID] .PubMed·Publisher's Site2015Evaluation of a Transcervical Foley Catheter as a Source of Infection: A Systematic Review and Meta-analysis.Obstetrics and gynecology.126(3):539-551[DOI] 10.1097/AOG.0000000000001002.[PMID] 26244535.55 citations·PubMed·Publisher's Site2015Failure to treat menopausal symptoms: a disconnect between clinical practice and scientific data.Menopause (New York, N.Y.).22(7):687-8[DOI] 10.1097/GME.0000000000000457.[PMID] 25850357.2 citations·PubMed·Publisher's Site2015Management of Menopausal Symptoms.Obstetrics and gynecology.126(4):859-876[DOI] 10.1097/AOG.0000000000001058.[PMID] 26348174.89 citations·PubMed·Publisher's Site2015NAMS supports judicious use of systemic hormone therapy for women aged 65 years and older.Menopause (New York, N.Y.).22(7):685-6[DOI] 10.1097/GME.0000000000000491.[PMID] 26035151.6 citations·PubMed·Publisher's Site2015New contraceptive patch wearability assessed by investigators and participants in a randomized phase 3 study.Contraception.91(3):211-6[DOI] 10.1016/j.contraception.2014.11.013.[PMID] 25586864.4 citations·PubMed·Publisher's Site2015Ovarian cysts: presence and persistence with use of a 13.5mg levonorgestrel-releasing intrauterine system.Contraception.91(5):412-7[DOI] 10.1016/j.contraception.2015.01.021.[PMID] 25661510.13 citations·PubMed·Publisher's Site2015Reply: To PMID 25448524.American journal of obstetrics and gynecology.213(6):879-[DOI] 10.1016/j.ajog.2015.08.023.[PMID] 26283456.PubMed·Publisher's Site2015Risk factors for endometrial cancer in black and white women: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2).Cancer causes & control : CCC.26(2):287-296[DOI] 10.1007/s10552-014-0510-3.[PMID] 25534916.35 citations·PubMed·Publisher's Site2015Safety and tolerability of a new low-dose contraceptive patch in obese and nonobese women.American journal of obstetrics and gynecology.212(3):318.e1-8[DOI] 10.1016/j.ajog.2014.09.014.[PMID] 25220709.7 citations·PubMed·Publisher's Site2015Self-reported and verified compliance in a phase 3 clinical trial of a novel low-dose contraceptive patch and pill.Contraception.91(3):204-10[DOI] 10.1016/j.contraception.2014.11.011.[PMID] 25582984.16 citations·PubMed·Publisher's Site2014Cervical and vaginal flora specimens are highly concordant with respect to bacterial vaginosis-associated organisms and commensal Lactobacillus species in women of reproductive age.Journal of clinical microbiology.52(8):3078-81[DOI] 10.1128/JCM.00795-14.[PMID] 24899020.17 citations·PubMed·Publisher's Site2014Comment on 'Practical advice for avoidance of pain associated with insertion of intrauterine contraceptives': authors' response.The journal of family planning and reproductive health care.40(3):235-[DOI] 10.1136/jfprhc-2014-100925.[PMID] 24939488.2 citations·PubMed·Publisher's Site2014Comment on 'practical advice for avoidance of pain associated with insertion of intrauterine contraceptives': authors' response.The journal of family planning and reproductive health care.40(2):152-3[DOI] 10.1136/jfprhc-2014-100874.[PMID] 24648536.PubMed·Publisher's Site2014Comment On `Practical Advice for Avoidance of Pain Associated With Insertion of Intrauterine Contraceptives': Authors' ResponseJournal of Family Planning and Reproductive Health Care.40(2):152-U82[DOI] 10.1136/jfprhc-2013-100848.[PMID] 24648535.2 citations·PubMed·Publisher's Site2014Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause.Menopause (New York, N.Y.).21(10):1082-90[DOI] 10.1097/GME.0000000000000210.[PMID] 24552977.16 citations·PubMed·Publisher's Site2014Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptive.Contraception.89(4):299-306[DOI] 10.1016/j.contraception.2014.01.013.[PMID] 24576794.14 citations·PubMed·Publisher's Site2014Extended duration use of menopausal hormone therapy.Menopause (New York, N.Y.).21(6):679-81[DOI] 10.1097/GME.0000000000000175.[PMID] 24398408.21 citations·PubMed·Publisher's Site2014Global fee prohibits postpartum provision of the most effective reversible contraceptives.Contraception.90(5):466-7[DOI] 10.1016/j.contraception.2014.08.005.[PMID] 25212061.36 citations·PubMed·Publisher's Site2014Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study.Menopause (New York, N.Y.).21(3):260-6[DOI] 10.1097/GME.0b013e31829a64f9.[PMID] 24045672.67 citations·PubMed·Publisher's Site2014In reply.Obstetrics and gynecology.123(5):1107-1108[DOI] 10.1097/AOG.0000000000000248.[PMID] 24785870.PubMed·Publisher's Site2014Injectable contraception: issues and opportunities.Contraception.89(5):331-4[DOI] 10.1016/j.contraception.2014.03.014.[PMID] 24767245.6 citations·PubMed·Publisher's Site2014Long-Term Issues in Hormone Therapy ManagementMenopause-the Journal of the North American Menopause Society.21(12):1322-[DOI] .[PMID] .PubMed·Publisher's Site2014Long-Term Safety of Unopposed Estrogen Used By Women Surviving Myocardial Infarction: 14-Year Follow-Up of the Esprit Randomised Controlled TrialBjog-An International Journal of Obstetrics and Gynaecology.121(6):705-5; discussion 705[DOI] 10.1111/1471-0528.12598.[PMID] 24533510.30 citations·PubMed·Publisher's Site2014Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial.Obstetrics and gynecology.123(2 Pt 1):295-303[DOI] 10.1097/AOG.0000000000000095.[PMID] 24402597.17 citations·PubMed·Publisher's Site2014Paroxetine 7.5 Mg Reduces Daily Frequency and Severity of Vasomotor Symptoms (Vms) Associated With Menopause: Results From 2 Multicenter, Randomized, Double-Blind, Controlled Phase 3 StudiesJournal of Womens Health.23(4):17-[DOI] .[PMID] .PubMed·Publisher's Site2014Practical advice for avoidance of pain associated with insertion of intrauterine contraceptives.The journal of family planning and reproductive health care.40(1):54-60[DOI] 10.1136/jfprhc-2013-100636.[PMID] 24076534.25 citations·PubMed·Publisher's Site2014The Association Between Vasomotor Symptoms and Hemostatic Factors in Postmenopausal WomenMenopause-the Journal of the North American Menopause Society.21(12):1332-1333[DOI] .[PMID] .PubMed·Publisher's Site2014The short-term prediction of preterm birth: a systematic review and diagnostic metaanalysis.American journal of obstetrics and gynecology.210(1):54.e1-54.e10[DOI] 10.1016/j.ajog.2013.09.004.[PMID] 24021995.55 citations·PubMed·Publisher's Site2014Why the product labeling for low-dose vaginal estrogen should be changed.Menopause (New York, N.Y.).21(9):911-6[DOI] 10.1097/GME.0000000000000316.[PMID] 25140698.55 citations·PubMed·Publisher's Site2013Bleeding Profile of a Novel Ascending-Dose, Extended-Regimen Ethinyl Estradiol/Levonorgestrel Combination Oral Contraceptive (Oc)Contraception.88():311-312[DOI] .[PMID] .PubMed·Publisher's Site2013Comment on journal review of 'Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture'.The journal of family planning and reproductive health care.39(4):306-[DOI] 10.1136/jfprhc-2013-100759.[PMID] 24062508.PubMed·Publisher's Site2013Contraception in women over 40 years of age.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.185(7):565-73[DOI] 10.1503/cmaj.121280.[PMID] 23460635.29 citations·PubMed·Publisher's Site2013Hormonal and intrauterine contraception for women aged 40 years and older.Women's health (London, England).9(5):421-4[DOI] 10.2217/whe.13.38.[PMID] 24007246.PubMed·Publisher's Site2013Impact On Body Weight and Sexual Function During Treatment of Vasomotor Symptoms (Vms) Due To Menopause With Low-Dose Mesylate Salt of Paroxetine (Ldmp)Menopause-the Journal of the North American Menopause Society.20(12):1320-[DOI] .[PMID] .PubMed·Publisher's Site2013Impact On Body Weight and Sexual Function During Treatment of Vasomotor Symptoms (Vms) Due To Menopause With Low-Dose Mesylate Salt of Paroxetine (Ldmp)Menopause-the Journal of the North American Menopause Society.20(12):1320-[DOI] .[PMID] .PubMed·Publisher's Site2013Is Uterine Leiomyomata Associated With Postmenopausal Bleeding? a Retrospective ReviewMenopause-the Journal of the North American Menopause Society.20(12):1334-[DOI] .[PMID] .PubMed·Publisher's Site2013Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.Obstetrics and gynecology.121(1):172-6[DOI] .[PMID] 23262943.59 citations·PubMed·Publisher's Site2013Low-Dose Mesylate Salt of Paroxetine (Ldmp) Reduced Daily Frequency and Severity of Vasomotor Symptoms (Vms) Due To MenopauseMenopause-the Journal of the North American Menopause Society.20(12):1340-1341[DOI] .[PMID] .PubMed·Publisher's Site2013Low-Dose Mesylate Salt of Paroxetine (Ldmp) Reduced Daily Frequency of Moderate Vasomotor Symptoms (Vms) and Severe Vms Due To MenopauseMenopause-the Journal of the North American Menopause Society.20(12):1340-[DOI] .[PMID] .PubMed·Publisher's Site2013Low-Dose Mesylate Salt of Paroxetine (Ldmp) Reduced Daily Frequency of Moderate Vasomotor Symptoms (Vms) and Severe Vms Due To MenopauseMenopause-the Journal of the North American Menopause Society.20(12):1340-[DOI] .[PMID] .PubMed·Publisher's Site2013Low-Dose Mesylate Salt of Paroxetine (Ldmp) Reduced Patient Burden of Menopausal Vasomotor SymptomsMenopause-the Journal of the North American Menopause Society.20(12):1348-[DOI] .[PMID] .PubMed·Publisher's Site2013Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials.Menopause (New York, N.Y.).20(10):1027-35[DOI] 10.1097/GME.0b013e3182a66aa7.[PMID] 24045678.82 citations·PubMed·Publisher's Site2013Management of pain associated with the insertion of intrauterine contraceptives.Human reproduction update.19(4):419-27[DOI] 10.1093/humupd/dmt022.[PMID] 23670222.30 citations·PubMed·Publisher's Site2013Should new-onset arthralgia be considered a menopausal symptom?Menopause (New York, N.Y.).20(6):591-3[DOI] 10.1097/GME.0b013e31828a6a3d.[PMID] 23549444.2 citations·PubMed·Publisher's Site2013Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.The journal of family planning and reproductive health care.39(3):156-9[DOI] 10.1136/jfprhc-2013-100624.[PMID] 23585363.17 citations·PubMed·Publisher's Site2013Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.18(3):143-7[DOI] 10.3109/13625187.2013.792637.[PMID] 23578274.10 citations·PubMed·Publisher's Site2013The levonorgestrel intrauterine system: effective non-surgical treatment for heavy menstrual bleeding.Evidence-based medicine.18(6):e57-[DOI] 10.1136/eb-2013-101275.[PMID] 23635841.PubMed·Publisher's Site2013The protein-to-creatinine ratio for the prediction of significant proteinuria in patients at risk for preeclampsia: a meta-analysis.Annals of clinical and laboratory science.43(2):211-20[DOI] .[PMID] 23694798.14 citations·PubMed·Publisher's Site2013Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture.Obstetrics and gynecology.121(3):593-600[DOI] 10.1097/AOG.0b013e318283d1a1.[PMID] 23635623.42 citations·PubMed·Publisher's Site2012Disparity in menopausal hormone therapy use between women obstetrician gynecologists and women overall: are obstetrician gynecologists underserving their patients?Menopause (New York, N.Y.).19(10):1070-1[DOI] .[PMID] 22929036.3 citations·PubMed·Publisher's Site2012Efficacy, safety, and tolerability of a monophasic oral contraceptive containing nomegestrol acetate and 17β-estradiol: a randomized controlled trial.Obstetrics and gynecology.119(5):989-99[DOI] 10.1097/AOG.0b013e318250c3a0.[PMID] 22525910.36 citations·PubMed·Publisher's Site2012Increased Compliance Independent of Patient Demographics With a Low-Dose Combination Contraceptive Patch (Ag200-15) Compared With a Low-Dose Combination Oral Contraceptive in a Phase 3 Clinical TrialContraception.86():314-[DOI] .[PMID] .PubMed·Publisher's Site2012Increased Compliance Independent of Patient Demographics With a Low-Dose Combination Contraceptive Patch (Ag200-15) Compared With a Low-Dose Combination Oral Contraceptive in a Phase 3 Clinical TrialContraception.86():314-[DOI] .[PMID] .PubMed·Publisher's Site2012Increased Compliance With a Low-Dose Combination Contraceptive Patch (Ag200-15) Compared With a Low-Dose Combination Oral Contraceptive (Coc) in a Phase 3 Clinical TrialContraception.86():178-[DOI] .[PMID] .PubMed·Publisher's Site2012Levonorgestrel-releasing intrauterine system for heavy menstrual bleeding improves hemoglobin and ferritin levels.Contraception.86(5):452-7[DOI] 10.1016/j.contraception.2012.07.018.[PMID] 22959906.23 citations·PubMed·Publisher's Site2012Study had insufficient power to investigate safety.BMJ (Clinical research ed.).345():e8146; author reply e8164-[DOI] 10.1136/bmj.e8146.[PMID] 23208257.4 citations·PubMed·Publisher's Site2012The 2010 North American Menopause Society Position Statement On Hormone Therapy Goes Beyond the Available Evidence ResponseMenopause-the Journal of the North American Menopause Society.19(7):836-837[DOI] 10.1097/gme.0b013e31825b32ea.[PMID] .PubMed·Publisher's Site2012The Levonorgestrel-Releasing Intrauterine System in Heavy Menstrual Bleeding a Benefit-Risk Review.72():193-215[DOI] .[PMID] .PubMed·Publisher's Site2012The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefit-risk review.Drugs.72(2):193-215[DOI] 10.2165/11598960-000000000-00000.[PMID] 22268392.44 citations·PubMed·Publisher's Site2012Transdermal and vaginal estradiol for the treatment of menopausal symptoms: the nuts and bolts.Menopause (New York, N.Y.).19(6):602-3[DOI] 10.1097/gme.0b013e31824c8a5a.[PMID] 22549171.8 citations·PubMed·Publisher's Site2011Incidental diagnosis of appendiceal mucocele with vaginal ultrasonography and computed tomography.Obstetrics and gynecology.117(2 Pt 2):479-481[DOI] 10.1097/AOG.0b013e318203ea37.[PMID] 21252796.4 citations·PubMed·Publisher's Site2011Removing the black box warning for depot medroxyprogesterone acetate.Contraception.84(3):212-3[DOI] 10.1016/j.contraception.2011.01.009.[PMID] 21843682.17 citations·PubMed·Publisher's Site2011Update on hormonal contraception and bone density.Reviews in endocrine & metabolic disorders.12(2):93-106[DOI] 10.1007/s11154-011-9180-6.[PMID] 21559817.44 citations·PubMed·Publisher's Site2010Cycle Control With a 21-Day Compared With a 24-Day Oral Contraceptive Pill: a Randomized Controlled Trial ReplyObstetrics and Gynecology.115(4):867-868[DOI] 10.1097/AOG.0b013e3181d7047e.[PMID] .PubMed·Publisher's Site2010Depot medroxyprogesterone acetate contraceptive injections and skeletal health.Women's health (London, England).6(3):339-42[DOI] 10.2217/whe.10.17.[PMID] 20426597.7 citations·PubMed·Publisher's Site2010Levonorgestrel-Releasing Intrauterine System Or Medroxyprogesterone for Heavy Menstrual Bleeding: a Randomized Controlled Trial ReplyObstetrics and Gynecology.116(6):1456-[DOI] 10.1097/AOG.0b013e3181ff7331.[PMID] .PubMed·Publisher's Site2010Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial.Obstetrics and gynecology.116(3):625-632[DOI] 10.1097/AOG.0b013e3181ec622b.[PMID] 20733445.97 citations·PubMed·Publisher's Site2010The Oncogenic Potential of Endometrial Polyps: a Systematic Review and Meta-AnalysisMenopause-the Journal of the North American Menopause Society.17():1233-[DOI] .[PMID] .PubMed·Publisher's Site2010The oncogenic potential of endometrial polyps: a systematic review and meta-analysis.Obstetrics and gynecology.116(5):1197-205[DOI] 10.1097/AOG.0b013e3181f74864.[PMID] 20966706.129 citations·PubMed·Publisher's Site2009Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptive.Contraception.79(5):350-5[DOI] 10.1016/j.contraception.2008.11.011.[PMID] 19341846.29 citations·PubMed·Publisher's Site2009An evidence-based approach to postpartum use of depot medroxyprogesterone acetate in breastfeeding women.Contraception.80(1):4-6[DOI] 10.1016/j.contraception.2008.12.014.[PMID] 19501209.12 citations·PubMed·Publisher's Site2009Cycle control with a 21-day compared with a 24-day oral contraceptive pill: a randomized controlled trial.Obstetrics and gynecology.114(6):1205-1212[DOI] 10.1097/AOG.0b013e3181beab47.[PMID] 19935020.21 citations·PubMed·Publisher's Site2009Depo-Provera and skeletal health: reviewing the evidence; developing and disseminating a consensus.Contraception.79(3):165-6[DOI] 10.1016/j.contraception.2008.06.017.[PMID] 19185667.2 citations·PubMed·Publisher's Site2009Diagnostic accuracy of transvaginal sonography for the diagnosis of adenomyosis: systematic review and metaanalysis.American journal of obstetrics and gynecology.201(1):107.e1-6[DOI] 10.1016/j.ajog.2009.03.021.[PMID] 19398089.88 citations·PubMed·Publisher's Site2009Effective herbal treatment of vasomotor symptoms--are we any closer?Menopause (New York, N.Y.).16(3):428-9[DOI] 10.1097/gme.0b013e31819774e4.[PMID] 19169160.PubMed·Publisher's Site2009Ethics and referral for abortion.American journal of obstetrics and gynecology.200(6):e9; author reply e9-10[DOI] 10.1016/j.ajog.2008.12.017.[PMID] 19286151.4 citations·PubMed·Publisher's Site2009Fetal fibronectin as a short-term predictor of preterm birth in symptomatic patients: a meta-analysis.Obstetrics and gynecology.114(3):631-640[DOI] 10.1097/AOG.0b013e3181b47217.[PMID] 19701045.76 citations·PubMed·Publisher's Site2009Levonorgestrel Intrauterine System and Medroxyprogesterone Acetate for Treatment of Heavy Menstrual BleedingContraception.80():212-[DOI] .[PMID] .PubMed·Publisher's Site2009Levonorgestrel-Releasing Intrauterine System and Endometrial Ablation in Heavy Menstrual Bleeding a Systematic Review and Meta-AnalysisObstetrics and Gynecology.113():1104-1116[DOI] .[PMID] .PubMed·Publisher's Site2009Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: a systematic review and meta-analysis.Obstetrics and gynecology.113(5):1104-1116[DOI] 10.1097/AOG.0b013e3181a1d3ce.[PMID] 19384127.80 citations·PubMed·Publisher's Site2009Postmenopausal osteoporosis: fracture risk and prevention.The Journal of family practice.58(11 Suppl Postmenopausal):S1-6[DOI] .[PMID] 19891943.13 citations·PubMed·Publisher's Site2009Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials.Fertility and sterility.91(5):1646-53[DOI] 10.1016/j.fertnstert.2008.02.140.[PMID] 18423453.121 citations·PubMed·Publisher's Site2009Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.Contraception.80(1):7-17[DOI] 10.1016/j.contraception.2009.02.005.[PMID] 19501210.72 citations·PubMed·Publisher's Site2009The use of depot-medroxyprogesterone acetate in contraception and its potential impact on skeletal health.Contraception.79(3):167-77[DOI] 10.1016/j.contraception.2008.10.016.[PMID] 19185668.27 citations·PubMed·Publisher's Site2009Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy.Menopause (New York, N.Y.).16(4):735-41[DOI] 10.1097/gme.0b013e318199e734.[PMID] 19252451.37 citations·PubMed·Publisher's Site2009Use of hormonal contraception in adolescents: skeletal health issues.Current opinion in obstetrics & gynecology.21(5):396-401[DOI] 10.1097/GCO.0b013e32832c9cc6.[PMID] 19491681.9 citations·PubMed·Publisher's Site2008Bone density recovery after depot medroxyprogesterone acetate injectable contraception use.Contraception.77(2):67-76[DOI] 10.1016/j.contraception.2007.10.005.[PMID] 18226668.82 citations·PubMed·Publisher's Site2008Clinical practice. Hormonal contraception in women of older reproductive age.The New England journal of medicine.358(12):1262-70[DOI] 10.1056/NEJMcp0708481.[PMID] 18354104.48 citations·PubMed·Publisher's Site2008Depo-Provera and skeletal health: a survey of Florida obstetrics and gynecologist physicians.Contraception.78(5):370-6[DOI] 10.1016/j.contraception.2008.07.022.[PMID] 18929733.16 citations·PubMed·Publisher's Site2008Depot Medroxyprogesterone Acetate and Skeletal Health: a Survey of Florida Ob/Gyn PhysiciansContraception.78(2):173-[DOI] 10.1016/j.contraception.2008.04.032.[PMID] .PubMed·Publisher's Site2008Do mechanical methods of cervical ripening increase infectious morbidity? A systematic review.American journal of obstetrics and gynecology.199(2):177-87; discussion 187[DOI] 10.1016/j.ajog.2008.05.005.[PMID] 18674661.80 citations·PubMed·Publisher's Site2008Metaanalysis of Diagnostic and Prognostic Studies: the Challenge Continues - ReplyAmerican Journal of Obstetrics and Gynecology.199(1):E16-E17[DOI] 10.1016/j.ajog.2008.02.040.[PMID] .PubMed·Publisher's Site2007Aromatase inhibitor therapy for uterine bleeding in a postmenopausal woman with leiomyomata.Menopause (New York, N.Y.).14(5):941-3[DOI] .[PMID] 17667148.8 citations·PubMed·Publisher's Site2007Cervical length and the risk of spontaneous labor at term.Journal of perinatology : official journal of the California Perinatal Association.27(12):749-53[DOI] .[PMID] 17762846.8 citations·PubMed·Publisher's Site2007Combined hormonal contraceptive trials: variable data collection and bleeding assessment methodologies influence study outcomes and physician perception.Contraception.75(1):4-10[DOI] .[PMID] 17161116.34 citations·PubMed·Publisher's Site2007Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trial.Obstetrics and gynecology.110(3):577-86[DOI] .[PMID] 17766603.49 citations·PubMed·Publisher's Site2007Long-acting contraceptives in adolescents.Current opinion in obstetrics & gynecology.19(5):453-60[DOI] .[PMID] 17885461.24 citations·PubMed·Publisher's Site2007Long-acting hormonal contraceptives--indispensable in preventing teen pregnancy.The Journal of adolescent health : official publication of the Society for Adolescent Medicine.40(1):1-3[DOI] .[PMID] 17185200.15 citations·PubMed·Publisher's Site2007Pharmacy access to emergency hormonal contraception in Jacksonville, FL: a secret shopper survey.Contraception.75(2):126-30[DOI] .[PMID] 17241842.25 citations·PubMed·Publisher's Site2007Progestin-releasing intrauterine systems and leiomyoma.Contraception.75(6 Suppl):S130-3[DOI] .[PMID] 17531604.34 citations·PubMed·Publisher's Site2007Recommendations for standardization of data collection and analysis of bleeding in combined hormone contraceptive trials.Contraception.75(1):11-5[DOI] .[PMID] 17161117.62 citations·PubMed·Publisher's Site2007Sonographic cervical assessment to predict the success of labor induction: a systematic review with metaanalysis.American journal of obstetrics and gynecology.197(2):186-92[DOI] .[PMID] 17689645.55 citations·PubMed·Publisher's Site2007Use of the levonorgestrel-IUD in the treatment of menorrhagia: improving patient outcomes while reducing the need for surgical management.Managed care interface.20(3):47-50[DOI] .[PMID] 17458481.1 citations·PubMed·Publisher's Site2006Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation.Contraception.74(2):90-9[DOI] .[PMID] 16860045.70 citations·PubMed·Publisher's Site2006Depot medroxyprogesterone acetate and bone mineral density in adolescents--the Black Box Warning: a Position Paper of the Society for Adolescent Medicine.The Journal of adolescent health : official publication of the Society for Adolescent Medicine.39(2):296-301[DOI] .[PMID] 16857545.92 citations·PubMed·Publisher's Site2006Hormone therapy and breast cancer risk: trumping fear with facts.Menopause (New York, N.Y.).13(2):160-3[DOI] .[PMID] 16645526.4 citations·PubMed·Publisher's Site2005Assessing the neonatal safety of indomethacin tocolysis: a systematic review with meta-analysis.Obstetrics and gynecology.106(1):173-9[DOI] .[PMID] 15994634.69 citations·PubMed·Publisher's Site2005Beyond the pill: new data and options in hormonal and intrauterine contraception.American journal of obstetrics and gynecology.192(4):998-1004[DOI] .[PMID] 15846172.16 citations·PubMed·Publisher's Site2005Contraceptive equity and access in the United States: a 2005 update.Contraception.71(5):317-8[DOI] .[PMID] 15854629.4 citations·PubMed·Publisher's Site2005Depo-Provera's black box: time to reconsider?Contraception.72(3):165-7[DOI] .[PMID] 16102548.25 citations·PubMed·Publisher's Site2005Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial.Obstetrics and gynecology.105(6):1389-96[DOI] .[PMID] 15932834.67 citations·PubMed·Publisher's Site2005Maternal death caused by midgut volvulus after bariatric surgery.American journal of obstetrics and gynecology.193(5):1748-9[DOI] .[PMID] 16260222.37 citations·PubMed·Publisher's Site2005Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials.Obstetrics and gynecology.105(2):273-9[DOI] .[PMID] 15684151.113 citations·PubMed·Publisher's Site2005Sublingual misoprostol for labor induction: a randomized clinical trial.Obstetrics and gynecology.105(2):365-71[DOI] .[PMID] 15684166.13 citations·PubMed·Publisher's Site2004Contraceptive efficacy and safety of DMPA-SC.Contraception.70(4):269-75[DOI] .[PMID] 15451329.111 citations·PubMed·Publisher's Site2004Enhancing oral contraceptive success: the potential of new formulations.American journal of obstetrics and gynecology.190(4 Suppl):S23-9[DOI] .[PMID] 15105795.9 citations·PubMed·Publisher's Site2004Randomized trial to compare perioperative outcomes of Filshie clip vs. Pomeroy technique for postpartum and intraoperative cesarean tubal sterilization: a pilot study.Contraception.69(4):267-70[DOI] .[PMID] 15033399.14 citations·PubMed·Publisher's Site2004Women's and providers' attitudes toward menstrual suppression with extended use of oral contraceptives.Contraception.70(5):359-63[DOI] .[PMID] 15504373.82 citations·PubMed·Publisher's Site2003Clinical characteristics of patients with an abnormal clomiphene citrate challenge test.American journal of obstetrics and gynecology.189(2):348-52; discussion 352[DOI] .[PMID] 14520190.2 citations·PubMed·Publisher's Site2003Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial.JAMA.290(13):1739-48[DOI] .[PMID] 14519708.345 citations·PubMed·Publisher's Site2003Human chorionic gonadotropin in cervicovaginal secretions as a predictor of preterm delivery.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.83(2):151-7[DOI] .[PMID] 14550589.16 citations·PubMed·Publisher's Site2003Labor induction versus expectant management for postterm pregnancies: a systematic review with meta-analysis.Obstetrics and gynecology.101(6):1312-8[DOI] .[PMID] 12798542.113 citations·PubMed·Publisher's Site2003Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance.Circulation.107(9):e67-8; author reply e67[DOI] .[PMID] 12628963.2 citations·PubMed·Publisher's Site2003Misoprostol use during the third stage of labor.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.82(2):143-52[DOI] .[PMID] 12873774.29 citations·PubMed·Publisher's Site2002Clinical manifestations of rotavirus infection in the neonatal intensive care unit.The Pediatric infectious disease journal.21(12):1099-105[DOI] .[PMID] 12488657.49 citations·PubMed·Publisher's Site2002Current concepts regarding use of DMPA.The Journal of reproductive medicine.47(9 Suppl):785-9[DOI] .[PMID] 12380407.7 citations·PubMed·Publisher's Site2002Expectant management versus labor induction for suspected fetal macrosomia: a systematic review.Obstetrics and gynecology.100(5 Pt 1):997-1002[DOI] .[PMID] 12423867.72 citations·PubMed·Publisher's Site2002Gynecologic problems of the perimenopause: evaluation and treatment.Obstetrics and gynecology clinics of North America.29(3):455-73[DOI] .[PMID] 12353668.3 citations·PubMed·Publisher's Site2002Hormone replacement therapy: where do we go now?The breast journal.8(6):329-31[DOI] .[PMID] 12390354.PubMed·Publisher's Site2002Labor induction with 25 microg versus 50 microg intravaginal misoprostol: a systematic review.Obstetrics and gynecology.99(1):145-51[DOI] .[PMID] 11777525.49 citations·PubMed·Publisher's Site2002Noncontraceptive health benefits of oral contraceptives.Reviews in endocrine & metabolic disorders.3(3):277-83[DOI] .[PMID] 12215722.5 citations·PubMed·Publisher's Site2002The effect of tablet moistening on labor induction with intravaginal misoprostol: a randomized trial.Obstetrics and gynecology.99(6):1080-4[DOI] .[PMID] 12052603.15 citations·PubMed·Publisher's Site2002Use of combination hormone replacement therapy in light of recent data from the Women's Health Initiative.Medscape women's health.7(4):8-[DOI] .[PMID] 12466740.6 citations·PubMed·Publisher's Site2001Adjunctive intravaginal metronidazole for the prevention of postcesarean endometritis: a randomized controlled trial.Obstetrics and gynecology.98(5 Pt 1):745-50[DOI] .[PMID] 11704163.32 citations·PubMed·Publisher's Site2001Current options for injectable contraception in the United States.Seminars in reproductive medicine.19(4):331-7[DOI] .[PMID] 11727175.6 citations·PubMed·Publisher's Site2001Injectable long-acting contraceptives.Clinical obstetrics and gynecology.44(1):73-91[DOI] .[PMID] 11219248.20 citations·PubMed·Publisher's Site2001Lunelle monthly injectable contraceptive. An effective, safe, and convenient new birth control option.Archives of gynecology and obstetrics.265(3):119-23[DOI] .[PMID] 11561738.9 citations·PubMed·Publisher's Site2001Oral contraceptive use in perimenopause.American journal of obstetrics and gynecology.185(2 Suppl):S32-7[DOI] .[PMID] 11521120.31 citations·PubMed·Publisher's Site2001Outpatient cervical ripening with intravaginal misoprostol.Obstetrics and gynecology.97(2):325-6[DOI] .[PMID] 11271511.3 citations·PubMed·Publisher's Site2001Route of breech delivery and maternal and neonatal outcomes.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.73(1):7-14[DOI] .[PMID] 11336715.23 citations·PubMed·Publisher's Site2001The hormone continuum: accrual of women's health benefits.International journal of fertility and women's medicine.46(2):60-72[DOI] .[PMID] 11374657.2 citations·PubMed·Publisher's Site2000Bleeding patterns of women using Lunelle monthly contraceptive injections (medroxyprogesterone acetate and estradiol cypionate injectable suspension) compared with those of women using Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol triphasic) or other oral contraceptives.Contraception.62(6):289-95[DOI] .[PMID] 11239615.18 citations·PubMed·Publisher's Site2000Cervical ripening and labor induction after previous cesarean delivery.Clinical obstetrics and gynecology.43(3):513-23[DOI] .[PMID] 10949755.40 citations·PubMed·Publisher's Site2000Efficacy, cycle control, and safety of two triphasic oral contraceptives: Cyclessa (desogestrel/ethinyl estradiol) and ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol): a randomized clinical trial.Contraception.61(5):295-302[DOI] .[PMID] 10906499.31 citations·PubMed·Publisher's Site2000Injectable contraception. New and existing options.Obstetrics and gynecology clinics of North America.27(4):741-80[DOI] .[PMID] 11091987.45 citations·PubMed·Publisher's Site2000Menstruation: choosing whether...and when.Contraception.62(6):277-84[DOI] .[PMID] 11239613.74 citations·PubMed·Publisher's Site2000Misoprostol for cervical ripening and labor induction: a systematic review of the literature.Clinical obstetrics and gynecology.43(3):475-88[DOI] .[PMID] 10949752.67 citations·PubMed·Publisher's Site2000Perinatal morbidity associated with misoprostol-induced labor.American journal of obstetrics and gynecology.182(3):749-50[DOI] .[PMID] 10739550.PubMed·Publisher's Site2000Prophylactic amnioinfusion for intrapartum oligohydramnios: a meta-analysis of randomized controlled trials.Obstetrics and gynecology.96(5 Pt 2):861-6[DOI] .[PMID] 11094242.12 citations·PubMed·Publisher's Site2000The effect of obstetric resident gender on forceps delivery rate.American journal of obstetrics and gynecology.182(5):1050-1[DOI] .[PMID] 10819824.11 citations·PubMed·Publisher's Site2000Uterine rupture associated with the use of prostaglandin E1 in patients with previous cesarean delivery.American journal of obstetrics and gynecology.182(4):990-1[DOI] .[PMID] 10764490.6 citations·PubMed·Publisher's Site1999Cervical ripening and labor induction with a controlled-release dinoprostone vaginal insert: a meta-analysis.Obstetrics and gynecology.94(5 Pt 2):878-83[DOI] .[PMID] 10546777.25 citations·PubMed·Publisher's Site1999Comparative safety, efficacy, and cycle control of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and Ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic). Lunelle Study Group.Contraception.60(4):179-87[DOI] .[PMID] 10640164.58 citations·PubMed·Publisher's Site1999Does smoking affect efficacy of the pill? Ask the experts.Contraceptive technology update.20(12):143-4[DOI] .[PMID] 12295560.1 citations·PubMed·Publisher's Site1999Efficacy of maintenance therapy after acute tocolysis: a meta-analysis.American journal of obstetrics and gynecology.181(2):484-90[DOI] .[PMID] 10454704.58 citations·PubMed·Publisher's Site1999Long-acting hormonal contraception: assessing impact on bone density, weight, and mood.International journal of fertility and women's medicine.44(2):110-7[DOI] .[PMID] 10338269.14 citations·PubMed·Publisher's Site1999Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): a contraceptive method for women in the US and worldwide.Contraception.60(4):177-8[DOI] .[PMID] 10640163.6 citations·PubMed·Publisher's Site1999Oral contraceptive health benefits: perception versus reality.Contraception.59(1 Suppl):29S-33S[DOI] .[PMID] 10342094.34 citations·PubMed·Publisher's Site1998Cesarean scar pregnancy: imaging and treatment with conservative surgery.Obstetrics and gynecology.91(5 Pt 2):838-40[DOI] .[PMID] 9572183.53 citations·PubMed·Publisher's Site1998Devices for endometrial sampling. A comparison.The Journal of reproductive medicine.43(3):180-4[DOI] .[PMID] 9564641.9 citations·PubMed·Publisher's Site1998Frequent urination and Depo-Provera. Ask the experts.Contraceptive technology update.19(12):160-1[DOI] .[PMID] 12321808.PubMed·Publisher's Site1998Infertility. A clinical guide for the internist.The Medical clinics of North America.82(2):271-95[DOI] .[PMID] 9531926.3 citations·PubMed·Publisher's Site1998Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians.International journal of fertility and women's medicine.43(2):73-83[DOI] .[PMID] 9609206.54 citations·PubMed·Publisher's Site1998Labor induction with prostaglandin E1 misoprostol compared with dinoprostone vaginal insert: a randomized trial.Obstetrics and gynecology.91(3):401-5[DOI] .[PMID] 9491868.79 citations·PubMed·Publisher's Site1998Oral contraceptive estrogen dose considerations.Contraception.58(3 Suppl):15S-21S; quiz 66S[DOI] .[PMID] 9807688.21 citations·PubMed·Publisher's Site1997Contraception for the adolescent patient.International journal of fertility and women's medicine.42(1):30-8[DOI] .[PMID] 9113833.6 citations·PubMed·Publisher's Site1997Estrogen component of OCs.Dialogues in contraception.5(4):1-6[DOI] .[PMID] 12293158.2 citations·PubMed·Publisher's Site1997Labor induction with intravaginal misoprostol in term premature rupture of membranes: a randomized study.Obstetrics and gynecology.89(6):909-12[DOI] .[PMID] 9170463.49 citations·PubMed·Publisher's Site1997Misoprostol for cervical ripening and labor induction: a meta-analysis.Obstetrics and gynecology.89(4):633-42[DOI] .[PMID] 9083326.169 citations·PubMed·Publisher's Site1997Oral administration of misoprostol for labor induction: a randomized controlled trial.Obstetrics and gynecology.90(1):153-4[DOI] .[PMID] 9207832.2 citations·PubMed·Publisher's Site1997Randomized trial of two doses of the prostaglandin E1 analog misoprostol for labor induction.American journal of obstetrics and gynecology.177(2):364-9; discussion 369[DOI] .[PMID] 9290452.58 citations·PubMed·Publisher's Site1997Reappearance of the intrauterine device: a 'user-friendly' contraceptive.International journal of fertility and women's medicine.42(2):120-7[DOI] .[PMID] 9160223.9 citations·PubMed·Publisher's Site1997The role of androgens in menopausal hormonal replacement.Endocrinology and metabolism clinics of North America.26(2):391-7[DOI] .[PMID] 9193891.8 citations·PubMed·Publisher's Site1996Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.The Journal of reproductive medicine.41(5 Suppl):419-27[DOI] .[PMID] 8725705.30 citations·PubMed·Publisher's Site1996Long-acting contraceptive options.International journal of fertility and menopausal studies.41(2):69-76[DOI] .[PMID] 8829701.19 citations·PubMed·Publisher's Site1996Randomized trial of oxytocin alone and with propranolol in the management of dysfunctional labor.Obstetrics and gynecology.88(4 Pt 1):517-20[DOI] .[PMID] 8841209.17 citations·PubMed·Publisher's Site1995A trial of labor complicated by uterine rupture following amnioinfusion.Southern medical journal.88(8):847-8[DOI] .[PMID] 7631213.5 citations·PubMed·Publisher's Site1995Calcium supplementation in mild preeclampsia remote from term: a randomized double-blind clinical trial.Obstetrics and gynecology.85(6):915-8[DOI] .[PMID] 7770260.21 citations·PubMed·Publisher's Site1995Contraception. A clinical review for the internist.The Medical clinics of North America.79(6):1377-409[DOI] .[PMID] 7475496.6 citations·PubMed·Publisher's Site1995Labor induction in patients with previous cesarean section.American journal of perinatology.12(6):450-4[DOI] .[PMID] 8579661.10 citations·PubMed·Publisher's Site1995Preinduction cervical ripening with commercially available prostaglandin E2 gel: a randomized, double-blind comparison with a hospital-compounded preparation.American journal of obstetrics and gynecology.173(4):1079-84[DOI] .[PMID] 7485297.14 citations·PubMed·Publisher's Site1995Pyelonephritis in pregnancy: once-a-day ceftriaxone versus multiple doses of cefazolin. A randomized, double-blind trial.American journal of obstetrics and gynecology.172(1 Pt 1):129-33[DOI] .[PMID] 7847521.24 citations·PubMed·Publisher's Site1994Cesarean section rates in teaching hospitals: a national survey.Birth (Berkeley, Calif.).21(4):194-6[DOI] .[PMID] 7857465.9 citations·PubMed·Publisher's Site1994Intravaginal misoprostol versus dinoprostone as cervical ripening and labor-inducing agents.Obstetrics and gynecology.83(5 Pt 1):799-801[DOI] .[PMID] 8164948.1 citations·PubMed·Publisher's Site1994Long-acting injectable contraception with depot medroxyprogesterone acetate.American journal of obstetrics and gynecology.170(5 Pt 2):1543-9[DOI] .[PMID] 8178904.75 citations·PubMed·Publisher's Site1994Prevention of pregnancy-induced hypertension by calcium supplementation in angiotensin II-sensitive patients.Obstetrics and gynecology.84(3):349-53[DOI] .[PMID] 8058229.81 citations·PubMed·Publisher's Site1994Resident research in obstetrics and gynecology.The Journal of reproductive medicine.39(8):635-8[DOI] .[PMID] 7996529.9 citations·PubMed·Publisher's Site1993ARHP launches Depo-Provera education program.Health and sexuality.3(3):18, 24-[DOI] .[PMID] 12286568.PubMed·Publisher's Site1993Combined oral contraception with desogestrel/ethinyl estradiol: tolerability profile.American journal of obstetrics and gynecology.168(3 Pt 2):1028-33[DOI] .[PMID] 8447356.13 citations·PubMed·Publisher's Site1993Injectable contraception with depot medroxyprogesterone acetate. Current status.Drugs.45(6):857-865[DOI] 10.2165/00003495-199345060-00001.[PMID] 7691495.16 citations·PubMed·Publisher's Site1993Labor induction with the prostaglandin E1 methyl analogue misoprostol versus oxytocin: a randomized trial.Obstetrics and gynecology.81(3):332-6[DOI] .[PMID] 8437780.142 citations·PubMed·Publisher's Site1992Detection of cervical Chlamydia trachomatis and Neisseria gonorrhoeae with deoxyribonucleic acid probe assays in obstetric patients.American journal of obstetrics and gynecology.167(3):588-91[DOI] .[PMID] 1530008.19 citations·PubMed·Publisher's Site1992Hygroscopic cervical dilators and prostaglandin E2 gel for preinduction cervical ripening. A randomized, prospective comparison.The Journal of reproductive medicine.37(4):355-9[DOI] .[PMID] 1593561.30 citations·PubMed·Publisher's Site1992Injectable contraception: the USA perspective.IPPF medical bulletin.26(6):1-3[DOI] .[PMID] 12346920.5 citations·PubMed·Publisher's Site1992Oral contraceptives and gynecologic cancer: an update for the 1990s.American journal of obstetrics and gynecology.167(4 Pt 2):1171-6[DOI] .[PMID] 1415442.13 citations·PubMed·Publisher's Site1991Calcium excretion in preeclampsia.Obstetrics and gynecology.77(4):510-3[DOI] .[PMID] 2002971.38 citations·PubMed·Publisher's Site1990Pseudotumor cerebri following eclampsia.European neurology.30(1):6-8[DOI] .[PMID] 2298229.1 citations·PubMed·Publisher's Site1990Reducing cesarean sections at a teaching hospital.American journal of obstetrics and gynecology.163(3):1081-7; discussion 1087[DOI] .[PMID] 2403133.53 citations·PubMed·Publisher's Site1989Injectable contraception.Clinical obstetrics and gynecology.32(2):356-68[DOI] .[PMID] 2525977.17 citations·PubMed·Publisher's Site1988Comparison of endometrial biopsy with the endometrial Pipelle and Vabra aspirator.The Journal of reproductive medicine.33(5):427-31[DOI] .[PMID] 3385697.91 citations·PubMed·Publisher's Site1988Successful pregnancy after previous conservative treatment of an advanced cervical pregnancy.Obstetrics and gynecology.71(6 Pt 2):1023-5[DOI] .[PMID] 3287250.36 citations·PubMed·Publisher's Site1987A physician's guide to adoption.JAMA.258(24):3537-41[DOI] .[PMID] 3316728.9 citations·PubMed·Publisher's Site1987Prenatal care and HIV screening.JAMA.258(19):2693-4[DOI] .[PMID] 3669236.21 citations·PubMed·Publisher's Site1986Maternal mortality in women aged 35 years or older: United States.JAMA.255(1):53-7[DOI] .[PMID] 3940305.45 citations·PubMed·Publisher's Site1986Mental retardation: a controversial indication for hysterectomy.Obstetrics and gynecology.68(3):436-8[DOI] .[PMID] 3737068.13 citations·PubMed·Publisher's Site1985Abortions that fail.Obstetrics and gynecology.66(4):533-7[DOI] .[PMID] 4047543.56 citations·PubMed·Publisher's Site1985Causes of maternal mortality in the United States.Obstetrics and gynecology.65(5):605-12[DOI] .[PMID] 3982738.272 citations·PubMed·Publisher's Site1984Maternal deaths in the United States by size of hospital.Obstetrics and gynecology.64(3):311-4[DOI] .[PMID] 6462559.13 citations·PubMed·Publisher's Site1984Maternal mortality surveillance, 1974-1978.MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.33(1):5SS-8SS[DOI] .[PMID] 6433176.1 citations·PubMed·Publisher's Site1984Outcome of out-of-hospital births should not be measured by birth weight.Public health reports (Washington, D.C. : 1974).99(5):435-436[DOI] .[PMID] 19313434.PubMed·Publisher's Site1984Perinatal and maternal mortality in a religious group avoiding obstetric care.American journal of obstetrics and gynecology.150(7):826-31[DOI] .[PMID] 6507508.79 citations·PubMed·Publisher's Site1984Progestogens, estrogen therapy, and endometrial cancer.Annals of internal medicine.100(2):316-[DOI] .[PMID] 6691683.1 citations·PubMed·Publisher's Site1984The Faith Assembly: a study of perinatal and maternal mortality.Indiana medicine : the journal of the Indiana State Medical Association.77(3):180-3[DOI] .[PMID] 6707460.8 citations·PubMed·Publisher's Site1983Abortion surveillance, 1979-1980.MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.32(2):1SS-7SS[DOI] .[PMID] 6621605.PubMed·Publisher's Site1982Point of law: what are the legal implications of prescribing and administering FDA-approved drugs in nonapproved ways?The Hospital medical staff.11(2):15-8[DOI] .[PMID] 10254209.PubMed·Publisher's Site1980Estrogen use in postmenopausal women.The New England journal of medicine.303(25):1477-8[DOI] .[PMID] 7432409.1 citations·PubMed·Publisher's Site1979Needle tract endometriosis: an unusual complication of amniocentesis.Obstetrics and gynecology.54(6):753-5[DOI] .[PMID] 160025.49 citations·PubMed·Publisher's Site Show More